الفهرسة نشطة
للباحثين للناشرين تسجيل الدخول إنشاء حساب
الرئيسية المؤلفون Mahmoud Aljurf
MA

Mahmoud Aljurf

h-8 H-Index
199 Citations
19 Papers

Published Papers

19 indexed
1
The Risk and Prognosis of COVID-19 Infection in Cancer Patients
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.1016/j.hemonc.2020.07.005
80 citations 396
2
Hepatitis-Associated Aplastic Anemia
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.1016/j.hemonc.2020.10.001
24 citations 387
3
Chimeric Antigen Receptor Structure and Manufacturing of Clinical Grade CAR Engineered Cells using Different Bioreactors
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.56875/2589-0646.1048
16 citations 389
4
Diagnosis and Treatment of Subcutaneous Panniculitis-like T-cell Lymphoma: A Systematic Literature Review
Hematology/Oncology and Stem Cell Therapy Q3 2023 10.1016/j.hemonc.2021.04.001
15 citations 390
5
Hematologic Manifestations of Parvovirus B19 Infection
Hematology/Oncology and Stem Cell Therapy Q3 2023 10.56875/2589-0646.1031
12 citations 390
6
Next-Generation Chimeric Antigen Receptor T-cells
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.56875/2589-0646.1035
11 citations 385
7
Infectious Complications and Preventative Strategies following Chimeric Antigen Receptor T-cells (CAR-T cells) Therapy for B-Cell Malignancies
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.56875/2589-0646.1049
10 citations 387
8
CAR-T cell Therapies for B-cell Lymphoid Malignancies
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.56875/2589-0646.1026
9 citations 388
9
Role of Anti-CD38 Monoclonal Antibodies in the Treatment of Adult Immune Hematological Diseases
Hematology/Oncology and Stem Cell Therapy Q3 2023 10.56875/2589-0646.1108
6 citations 391
10
Current Practice of Oral Care for Hematopoietic Stem Cell Transplant Patients: A Survey of the Eastern Mediterranean Blood and Marrow Transplantation Group
Hematology/Oncology and Stem Cell Therapy Q3 2023 10.1016/j.hemonc.2021.01.006
5 citations 394
11
H syndrome: A histiocytosis-lymphadenopathy plus syndrome. A comprehensive review of the literature
Hematology/Oncology and Stem Cell Therapy Q3 2024 10.4103/hemoncstem.hemoncstem-d-24-00004
5 citations 390
12
Emerging Role of Autologous CD19 CAR T-Cell Therapies in the Second-Line Setting for Large B-cell Lymphoma
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.56875/2589-0646.1025
3 citations 389
13
Acquired factor XIII deficiency in myeloid neoplasms: case series and review of literature
Hematology/Oncology and Stem Cell Therapy Q3 2024 10.4103/hemoncstem.hemoncstem-d-24-00034
2 citations 387
14
Improved long-term survival rate in the responders to bortezomib, cyclophosphamide, dexamethasone induction therapy in a transplant-eligible cohort of predominantly middle-age multiple myeloma patients
Annals of Saudi Medicine Q1 2024 10.5144/0256-4947.2024.93
1 citations 2,140
15
Unique aspects of Graft-versus-host-disease management in the Eastern Mediterranean region: Report from the Eastern Mediterranean blood and marrow transplantation group: Special report
Hematology/Oncology and Stem Cell Therapy Q3 2023 10.1016/j.hemonc.2020.04.003
0 citations 391
16
Framework for Patient Advocacy in Hematopoietic Cell Transplantation (HCT): An Overview from the Worldwide Network for Blood and Marrow Transplantation
Hematology/Oncology and Stem Cell Therapy Q3 2025 10.4103/hemoncstem.hemoncstem-d-24-00054
0 citations 392
17
Cancer epidemiology in the Kingdom of Saudi Arabia, 2024
Hematology/Oncology and Stem Cell Therapy Q3 2026 10.4103/hemoncstem.hemoncstem-d-26-00008
0 citations 393
18
Progressive transformation of germinal centers: Bridging clinical and pathological insights for diagnostic precision
Hematology/Oncology and Stem Cell Therapy Q3 2026 10.4103/hemoncstem.hemoncstem-d-25-00052
0 citations 389
19
Impact of mental health on outcomes of patients with relapsed and/or refractory diffuse large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy
Hematology/Oncology and Stem Cell Therapy Q3 2026 10.4103/hemoncstem.hemoncstem-d-26-00018
0 citations 387

Publication Activity

Journals Published In

Annals of Saudi Medicine
🇸🇦 Q1 AMS 90
Hematology/Oncology and Stem Cell Therapy
🇸🇦 Q3 AMS 72